IN2015KN00492A - - Google Patents
Info
- Publication number
- IN2015KN00492A IN2015KN00492A IN492KON2015A IN2015KN00492A IN 2015KN00492 A IN2015KN00492 A IN 2015KN00492A IN 492KON2015 A IN492KON2015 A IN 492KON2015A IN 2015KN00492 A IN2015KN00492 A IN 2015KN00492A
- Authority
- IN
- India
- Prior art keywords
- compounds
- diseases
- conditions
- diabetes
- infection
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
- C07H15/06—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical being a hydroxyalkyl group esterified by a fatty acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Otolaryngology (AREA)
- Ophthalmology & Optometry (AREA)
- Endocrinology (AREA)
- Transplantation (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NZ60147312 | 2012-07-26 | ||
| PCT/NZ2013/000133 WO2014017928A1 (en) | 2012-07-26 | 2013-07-26 | Organic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2015KN00492A true IN2015KN00492A (da) | 2015-07-17 |
Family
ID=49997620
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN492KON2015 IN2015KN00492A (da) | 2012-07-26 | 2013-07-26 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US9586985B2 (da) |
| EP (1) | EP2877481B1 (da) |
| JP (1) | JP6528029B2 (da) |
| KR (1) | KR102162619B1 (da) |
| CN (1) | CN104736550B (da) |
| AU (1) | AU2013293646B2 (da) |
| CA (1) | CA2880191C (da) |
| IN (1) | IN2015KN00492A (da) |
| WO (1) | WO2014017928A1 (da) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105008380B (zh) * | 2012-12-06 | 2018-01-23 | 维多利亚联结有限公司 | 缀合化合物 |
| WO2014200363A1 (en) * | 2013-06-10 | 2014-12-18 | Victoria Link Limited | Sphingoglycolipid analogues |
| WO2015187040A1 (en) * | 2014-06-05 | 2015-12-10 | Regan James Anderson | Amino sphingoglycolipid analogues |
| JP6453033B2 (ja) * | 2014-10-22 | 2019-01-16 | 国立大学法人北海道大学 | 糖スフィンゴシン及びスフィンゴ塩基の製造方法 |
| US9394312B1 (en) * | 2015-06-14 | 2016-07-19 | Mark Quang Nguyen | Ibrutinib prodrugs, pharmaceutical compositions thereof, and methods of use |
| US10723750B2 (en) | 2015-11-13 | 2020-07-28 | La Jolla Institute For Allergy And Immunology | Sphingamide compounds and methods for binding iNKT cells |
| US10919926B2 (en) | 2016-03-22 | 2021-02-16 | Keio University | Compound or salt thereof, natural killer T cell activator, and pharmaceutical composition |
| WO2019122050A1 (en) | 2017-12-22 | 2019-06-27 | Isa Pharmaceuticals B.V. | Methods of immunization |
| EP4308170A1 (en) | 2021-03-18 | 2024-01-24 | Seagen Inc. | Selective drug release from internalized conjugates of biologically active compounds |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4410913B2 (ja) * | 2000-06-12 | 2010-02-10 | 壽製薬株式会社 | 新規糖脂質誘導体の製造方法 |
| AU2003225891A1 (en) | 2003-03-20 | 2004-11-19 | Brigham Young University | 6"-amino-6"-deoxygalactosylceramides |
| JP3824319B2 (ja) | 2004-02-19 | 2006-09-20 | 株式会社紀文フードケミファ | 抗ウイルス作用組成物 |
| US20060024691A1 (en) | 2004-03-25 | 2006-02-02 | Buck Institute For Age Research | Novel pathways in the etiology of cancer |
| AU2005280163B2 (en) * | 2004-08-27 | 2011-11-24 | Albert Einstein College Of Medicine, Inc. | Ceramide derivatives as modulators of immunity and autoimmunity |
| JP5090928B2 (ja) | 2004-12-28 | 2012-12-05 | ザ ロックフェラー ユニバーシティ | Ｎｋｔ細胞に対する抗原としての糖脂質及びその類似体 |
| US7923013B2 (en) * | 2004-12-28 | 2011-04-12 | The Rockefeller University | Glycolipids and analogues thereof as antigens for NKT cells |
| US20090117089A1 (en) * | 2005-09-19 | 2009-05-07 | The Rockefeller University | Glycolipids and analogues thereof as antigens for nk t cells |
| WO2008047174A1 (en) * | 2006-10-18 | 2008-04-24 | Centre National De La Recherche Scientifique | Alpha-galactosylceramide analogs, their methods of manufacture, intermediate compounds useful in these methods, and pharmaceutical compositions containing them |
| US20080133801A1 (en) * | 2006-12-04 | 2008-06-05 | Aten International Co., Ltd. | Keyboard-video-mouse switch system for switching between computers having a plurality of video sources each and switching method thereof |
| EP2698353B1 (en) | 2007-04-12 | 2024-02-07 | Novozymes Biologicals, Inc. | Wastewater treatment using microbial strains |
| EP2058011A1 (en) | 2007-11-07 | 2009-05-13 | Wittycell | Nkt cell activating gycolipids covalently bound antigens and/or drug |
| US9220767B2 (en) * | 2008-10-08 | 2015-12-29 | Abivax | Vaccine composition for use against influenza |
-
2013
- 2013-07-26 KR KR1020157004813A patent/KR102162619B1/ko active IP Right Grant
- 2013-07-26 WO PCT/NZ2013/000133 patent/WO2014017928A1/en active Application Filing
- 2013-07-26 US US14/417,487 patent/US9586985B2/en active Active
- 2013-07-26 AU AU2013293646A patent/AU2013293646B2/en not_active Ceased
- 2013-07-26 CN CN201380050112.1A patent/CN104736550B/zh not_active Expired - Fee Related
- 2013-07-26 CA CA2880191A patent/CA2880191C/en active Active
- 2013-07-26 JP JP2015524218A patent/JP6528029B2/ja not_active Expired - Fee Related
- 2013-07-26 EP EP13823249.1A patent/EP2877481B1/en active Active
- 2013-07-26 IN IN492KON2015 patent/IN2015KN00492A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20150073942A (ko) | 2015-07-01 |
| US9586985B2 (en) | 2017-03-07 |
| CA2880191A1 (en) | 2014-01-30 |
| CN104736550B (zh) | 2017-12-29 |
| US20150191503A1 (en) | 2015-07-09 |
| JP2015522656A (ja) | 2015-08-06 |
| AU2013293646A1 (en) | 2015-03-12 |
| JP6528029B2 (ja) | 2019-06-12 |
| AU2013293646B2 (en) | 2017-10-19 |
| CA2880191C (en) | 2021-04-20 |
| EP2877481B1 (en) | 2019-11-27 |
| WO2014017928A1 (en) | 2014-01-30 |
| CN104736550A (zh) | 2015-06-24 |
| EP2877481A1 (en) | 2015-06-03 |
| EP2877481A4 (en) | 2016-04-06 |
| KR102162619B1 (ko) | 2020-10-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2015KN00492A (da) | ||
| AU2018236800B2 (en) | DNA-PK inhibitors | |
| NZ708727A (en) | Conjugate compounds | |
| PH12016501966A1 (en) | Compounds and compositions as toll-like receptor 7 agonists | |
| PH12016501192A1 (en) | Tetrahydropyridopyrazines modulators of gpr6 | |
| NZ724878A (en) | Compounds and compositions as toll-like receptor 7 agonists | |
| MX2017005834A (es) | Polinucleotidos aad para el tratamiento de la enfermedad de parkinson. | |
| MD20150091A2 (ro) | Compuşi antivirali | |
| GEP201706695B (en) | Substituted 4-phenyl-pyridi-nes for the treatment of nk-1 receptor related diseases | |
| TW201613901A (en) | New compounds | |
| WO2015085318A3 (en) | Targeted adaptive vaccines | |
| NZ700928A (en) | Dna-pk inhibitors | |
| PH12019502363A1 (en) | Phenyl-2-hydroxy-acetylamino-2-methyl-phenyl compounds | |
| MY165579A (en) | Synthetic methods for spiro-oxindole compounds | |
| EA201490423A1 (ru) | СПОСОБЫ И КОМПОЗИЦИИ, ОТНОСЯЩИЕСЯ К p62, ДЛЯ ЛЕЧЕНИЯ И ПРОФИЛАКТИКИ РАКА | |
| PH12017500401A1 (en) | Therapeutic compounds as inhibitors of the orexin-1 receptor | |
| MX2020006237A (es) | Compuestos para el tratamiento de enfermedades relacionadas con la expresion de dux4. | |
| WO2013120022A3 (en) | Treatment of hypoglycemia | |
| PH12014502032A1 (en) | Treatment of brain cancer | |
| MY180844A (en) | Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions | |
| WO2014086453A8 (en) | Azaheterobicyclic compounds | |
| MY192609A (en) | Substituted bicyclic heteroaryl compounds as rxr agonists | |
| IN2013MU03118A (da) | ||
| PH12017501872A1 (en) | Methods of treating diseases | |
| PH12017501147A1 (en) | Total synthesis of trioxacarcin dc-45-a2 and preparation of trioxacarcin analogs |